Trial · NCT04707573
Results by group60
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 60
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Cohort 1: CKD Stage 3 Vadadustat | 6 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Cohort 2: CKD Stage 4 Vadadustat | 2 | Participants | ||
| Number of Participants With Clinically Significant Changes From Baseline in Laboratory Parameter Values | Cohort 1: CKD Stage 3 Vadadustat | Urinalysis | 0 | Participants | |
| Number of Participants With Clinically Significant Changes From Baseline in Laboratory Parameter Values | Cohort 2: CKD Stage 4 Vadadustat | Urinalysis | 0 | Participants | |
| Number of Participants With Clinically Significant Changes From Baseline in Laboratory Parameter Values | Cohort 1: CKD Stage 3 Vadadustat | Hematology | 0 | Participants | |
| Number of Participants With Clinically Significant Changes From Baseline in Laboratory Parameter Values | Cohort 2: CKD Stage 4 Vadadustat | Hematology | 0 | Participants | |
| Number of Participants With Clinically Significant Changes From Baseline in Laboratory Parameter Values | Cohort 1: CKD Stage 3 Vadadustat | Serum chemistry | 1 | Participants | |
| Number of Participants With Clinically Significant Changes From Baseline in Laboratory Parameter Values | Cohort 2: CKD Stage 4 Vadadustat | Serum chemistry | 0 | Participants | |
| Number of Participants With Clinically Significant Changes From Baseline in Laboratory Parameter Values | Cohort 1: CKD Stage 3 Vadadustat | Coagulation | 0 | Participants | |
| Number of Participants With Clinically Significant Changes From Baseline in Laboratory Parameter Values | Cohort 2: CKD Stage 4 Vadadustat | Coagulation | 0 | Participants | |
| Number of Participants With Clinically Significant Changes From Baseline in Vital Sign Values | Cohort 1: CKD Stage 3 Vadadustat | 2 | Participants | ||
| Number of Participants With Clinically Significant Changes From Baseline in Vital Sign Values | Cohort 2: CKD Stage 4 Vadadustat | 0 | Participants | ||
| Number of Participants With Clinically Abnormal 12-Lead Electrocardiogram (ECG) Findings | Cohort 1: CKD Stage 3 Vadadustat | 0 | Participants | ||
| Number of Participants With Clinically Abnormal 12-Lead Electrocardiogram (ECG) Findings | Cohort 2: CKD Stage 4 Vadadustat | 0 | Participants | ||
| Change From Baseline in PR Interval, QT Interval, QRS Interval, and QT Corrected (QTc) Interval | Cohort 1: CKD Stage 3 Vadadustat | Baseline PR interval | 178.8 | Standard Deviation 44.2 | Milliseconds |
| Change From Baseline in PR Interval, QT Interval, QRS Interval, and QT Corrected (QTc) Interval | Cohort 2: CKD Stage 4 Vadadustat | Baseline PR interval | 182.5 | Standard Deviation 24.2 | Milliseconds |
| Change From Baseline in PR Interval, QT Interval, QRS Interval, and QT Corrected (QTc) Interval | Cohort 1: CKD Stage 3 Vadadustat | Change from Baseline at Day 2 PR interval | -12.4 | Standard Deviation 28.4 | Milliseconds |
| Change From Baseline in PR Interval, QT Interval, QRS Interval, and QT Corrected (QTc) Interval | Cohort 2: CKD Stage 4 Vadadustat | Change from Baseline at Day 2 PR interval | -3.5 | Standard Deviation 5.5 | Milliseconds |
| Change From Baseline in PR Interval, QT Interval, QRS Interval, and QT Corrected (QTc) Interval | Cohort 1: CKD Stage 3 Vadadustat | Baseline QRS interval | 98.8 | Standard Deviation 20.7 | Milliseconds |
| Change From Baseline in PR Interval, QT Interval, QRS Interval, and QT Corrected (QTc) Interval | Cohort 2: CKD Stage 4 Vadadustat | Baseline QRS interval | 97.7 | Standard Deviation 26.0 | Milliseconds |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04707573/results